December 12, 2023 Comments Off on New patent for Boehringer Ingelheim drug PRADAXA Posted in: Patent Added Annual Drug Patent Expirations for PRADAXA Pradaxa is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from four suppliers. There are four patents…
The post New patent for Boehringer Ingelheim drug PRADAXA appeared f…
December 12, 2023 Comments Off on New patent for Kaleo Inc drug AUVI-Q Posted in: Patent Added Annual Drug Patent Expirations for AUVI-Q Auvi-q is a drug marketed by Kaleo Inc and is included in one NDA. It is available from three suppliers. There are thirty-one patents…
The post New patent for Kaleo Inc drug AUVI-Q appeared first on DrugPatentW…